PREVALENCE OF HEPATITIS B AND C VIRAL INFECTIONS IN PREGNANT WOMEN ATTENDING ANTENATAL CLINIC IN NNEWI, NIGERIA by Oluboyo, B.O et al.
European Scientific Journal   January 2014  edition vol.10, No.3  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
434 
PREVALENCE OF HEPATITIS B AND C VIRAL 
INFECTIONS IN PREGNANT WOMEN 
ATTENDING ANTENATAL CLINIC IN NNEWI, 
NIGERIA 
 
 
 
Oluboyo, B.O 
Department of Human Virology, Nnamdi Azikiwe University Teaching 
Hospital (NAUTH), Nnewi, Nigeria 
Ugochukwu,V.I 
Oluboyo,A.O 
Ihim,A.C 
Chukwuma, G.O 
Ogenyi S.I 
Onyemelukwe, A 
Department of Medical Laboratory Science,  
Faculty of Health Sciences and Technology, College of Health Sciences, 
Nnamdi Azikiwe University, Nnewi Campus, Nigeria 
 
 
Abstract 
Infections due to Hepatitis B and C viruses are significant health 
problems around the globe, Nigeria inclusive. This study was conducted 
among 100 pregnant women attending ante natal clinic at NnamdiAzikiwe 
University Teaching Hospital, Nnewi, Anambra State, Nigeria to determine 
the seroprevalence of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) 
and to determine whether liver amino transferases can be affected. The blood 
samples were tested for hepatitis B surface antigen (HBsAg) and Anti-HCV 
using HBsAg and Anti-HCV one step rapid test strip and furthermore using 
ELISA technique. Serum alanine aminotransferase (ALT) and serum 
aspartate aminotransferase (AST) activities were also estimated in all the 
subjects using Reitman - Frankel method. The  results showed that six 
percent(6%) and one percent (1%) of the 100 blood samples tested positive 
for HBV and HCV respectively. The mean AST levels for HBsAg negative 
and positive subjects were 10.55±2.36 and 12.17±2.23 respectively while the 
mean ALT levels were 5.54±1.94and 8.00±3.10 respectively. The mean AST 
for anti-HCV negative and positive subjects were 10.67±2.38 and 9.00±0.00 
respectively while the ALT were 5.71±2.09 and 4.00±0.00 respectively. 
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There was significant increase in the levels of ALT between the HBsAg 
positive and negative pregnant subjects (P<0.05). HBV and HCV infection 
can be present in pregnant women and can alter liver amino transferases. 
Therefore testing for HBsAg and Anti-HCV is recommended for all pregnant 
women at first prenatal and postnatal visit so that HBsAg and HCV positive 
mothers will receive prompt intervention. 
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Introduction 
Hepatitis B virus (HBV) is a DNA virus of the family 
hepadnaviridae and the causative agent of hepatitis B infection 
(Pungpaponget al, 2007). It is 50 - 100 times more infectious than HIV and 
10 times more infectious than hepatitis C virus (HCV). Many carriers do not 
realize they are infected with the virus, thus it is referred to as a “silent 
killer” (Samuel et al, 2004). The minimum infectious dose is so low that 
such practices like sharing a tooth brush or a razor blade can transmit 
infection (Chang, 2008). HBV also shares similar routes of transmission with 
HIV (Willey et al, 2008). Approximately 350 million people are infected 
with HBV worldwide (Liu and Hou, 2006; Eke et al, 2011) with Nigeria 
classified among the group of countries endemic for HBV infection. 
Hepatitis C virus is an RNA virus of the flaviviridaefamily and appears to 
have humans and chimpanzees as the only species susceptible to its infection 
(Polyak, 2006). About 170 million people are infected with HCV worldwide 
(Liu and Hou, 2006). Apart from being detected in blood, it has also been 
detected in semen (Cavalleroet al, 2008) and saliva (Chen et al, 2009).  
HBV and HCV account for a substantial portion of liver diseases 
worldwide and infected individuals can remain asymptomatic for decades. 
However, more than 80% of them become chronic carriers which result in an 
increased risk of liver cirrhosis, liver cancer and liver failure 20 - 30 years 
later (Volfet al, 2008). They share similar modes of transmission; co-
infection is not uncommon especially in areas of high prevalence and among 
people at high risk for parenteral infection (Liu and Hou, 2006). In Nigeria, 
the prevalence rates of HBV and HCV in pregnant women differ from one 
locality to another. Yakasai et al (2012) reported a prevalence of 7.9 and 
7.6% among HBsAg among pregnant women and nonpregnant women 
respectively in Kano, Nigeria while Oladeindeet al (2013) reported a 
prevalent rate of 8 (2.2%) and 3 (0.8%) of HBV and HCV infections among 
pregnant women in Benin City, Nigeria. Co-infection of HBV and HCV 
seems to result in more severe disease than either infection alone. Others 
may have overt symptomatic liver disease with anorexia, nausea, right upper 
quadrant pain, dark urine, and pruritus. Measurements of serum amino 
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transferases have remained the most useful test for the routine diagnosis of 
liver diseases during pregnancy (Ali et al, 2012). Changes in the value of 
certain serum liver function tests occur during normal pregnancy and an 
understanding of these physiological changes is necessary for the 
management of liver diseases.  However, HCV and HBV can be prevented 
by early detection and therapy (Xuanet al, 2007). Thus, the study aimed to 
determine the prevalence of HBV and HCV in pregnant women and to 
determine whether liver amino transferases can be affected. 
 
Materials And Methods 
  This study was carried out in the ante-natal clinic of NnamdiAzikiwe 
University Teaching Hospital (NAUTH), Nnewi, Anambra State of Nigeria.  
  Blood samples were collected from 100 pregnant women who 
volunteered to participate in the study after a counseling session. One step 
HBsAg strip by ACON Laboratories incorporated, USA and One step Anti-
HCV strip by ACON Laboratories incorporated, USA. The ACON HBsAg 
and Anti-HCV device, a rapid chromatographic immunoassay for the 
qualitative detection of Hepatitis B surface antigen and HCV in 
serum/plasma was used for screening the participants. Those who were 
positive were further tested for positivity using MonolisaHBsAg Ultra kits 
from BIO-RAD and Enzyme immunoassay kits for anti-HCV in serum from 
Diagnostic Bioprobes, Italy. Serum alanine aminotransferase (ALT) and 
serum aspartate aminotransferase (AST) activities were estimated in all the 
subjects using Reitman - Frankel method. 
 
Statistical Analysis 
The prevalence of each viral infection (HBV and HCV) was 
determined from the proportion of the positive individuals in the total 
population under consideration and expressed as a percentage. The chi-
square test was employed to determine the relationships between age and 
presence of risk factors with HBV and HCV infection at p<0.05.  
 
Results 
The results of the prevalence study are presented in the table 1. It 
shows that out of the 100 pregnant women tested, 6 were positive for HBsAg 
and 1 was positive for anti-HCV giving an overall prevalence of 6% and 1% 
respectively. Table 2 shows the prevalence of HBsAg and Anti-HCV among 
the women based on age groups. The prevalence of HBsAg was highest 
among the age group (15-20 years) while Anti-HCV was seen in age group 
(21-26 years). Table 3shows thepercentage of those with history of blood 
transfusion that were positive for both HBsAg and Anti-HCV as 7.7% and 
those with no history of  blood transfusion that were positive for HBsAg and 
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Anti-HCV as 5.7% and 0% respectively.There was no significant difference 
in HBV when those who had blood transfusion and those who did not were 
compared but there was significant difference in HCV. Thepercentage of 
those with history of surgery that were positive for both HBsAg and Anti-
HCV was 3.2% and those with no history of surgery who were positive for 
HBsAg and Anti-HCV were 7.2% and 0% respectively.However, there was 
no significant difference between them. Thepercentage of those who used 
contraceptives and positive for HBsAg and Anti-HCV were 13.6% and 0% 
respectively while those who do not use contraceptives and were positive for 
HBsAg and Anti-HCV were 3.8% and 1.3% respectively. There was no 
significant difference. Furthermore, thepercentage of those who had hepatitis 
who were positive for HBsAg and Anti-HCV were 5.6% and 0% 
respectively and those who were not positive for HBsAg and Anti-HCV 
were 6.1% and 1.2% respectively.There was also no significant difference 
when compared. 
  Table 4shows the mean AST levels for HBsAg negative and positive 
subjects were 10.55±2.36 and 12.17±2.23 respectively while the mean ALT 
levels were 5.54±1.94 and 8.00±3.10 respectively. There was no significant 
difference in mean AST levels between those who were HBsAg positive and 
those that were negative but there was a significant difference in their mean 
ALT levels (P<0.05) when compared. The mean AST level for anti-HCV 
negative and positive subjects were 10.67±2.38 and 9.00±0.00 respectively 
while their mean ALT are 5.71±2.09 and 4.00±0.00 respectively. There was 
no significant difference in mean AST and ALT levels between those who 
were HCV positive and those who were negative when compared. 
Table 1: Prevalence of HBV and HBC in the Pregnant Women 
Hepatitis serology Number tested Positive result (%) Negative result (%) 
HBsAg 100 6 94 
Anti-HCV 100 1 99 
 
Table 2: Prevalence of HBsAg and Anti-HCV among the women based on Age Groups 
 
 
 
 
 
Age group (year) Number 
Tested 
% HBsAg positivity 
 
%Anti-HCV 
Positivity 
15-20 5 20 0 
21-26 22 9.1 4.5 
27-33 46 4.3 0 
34-40 25 4 0 
> 40 2 0 0 
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Table 3: Prevalence of HBsAg and Anti-HCV in Relation to Associated Risk Factors 
among the Pregnant Women 
Significance= p<0.05 
*= significant,     X2= Chi-square 
 
TABLE 4: T-test for AST and ALT among the pregnant women tested. 
Parameter Status Mean ± SD (IU/L) P value 
HBsAg 
 
 
 
AST 
 
Negative (n=94) 
Positive (n=6) 
10.55±2.36 
12.17±2.23 
0.106 
 
ALT Negative (n=94) 
Positive (n=6) 
5.54±1.94 
8.00±3.10 
0.005* 
Anti-
HCV 
AST 
 
Negative (n=99) 
Positive (n=1) 
10.67±2.38 
9.00±0.00 
0.487 
 
 
ALT 
Negative (n=99) 
Positive (n=1) 
5.71±2.09 
4.00±0.00 
0.419 
Significance= p<0.05 
*= significant,   SD= standard deviation 
 
Discussion 
The prevalence of hepatitis B and C infections varies in different 
parts of the world from country to country, and from one region to another 
region and from one population group to another in a country (Zaliet al., 
1996) and since pregnant women have depressed immunity; infections of 
HBV and HCV are of clinical importance.  
This study shows that the prevalence of HBV in the pregnant women 
is within the intermediate range of prevalence. This result is in line with 
some works which have been done in many parts of the country where a high 
incidence of hepatitis B had been detected (Mbaawuaga et al., 2005;Ndams 
et al., 2008; Luka et al., 2008). However, lower reports were given in some 
other places (Akaniet al., 2005; Obi et al., 2006; Ezeaniet al., 2008; 
Onakewhoret al., 2008). Our results also showed that out of the 100 
respondents, the highest prevalence for HBsAg were within the age group 
15-20 years. The prevalence of HCV antibodies in the pregnant population is 
lower than those reported among pregnant women in some other parts of the 
country (Baba et al., 1999; Onakewhoret al., 2008). This prevalence is in 
line with similar studies on pregnant women from the Guinea and Côte 
Risk Factors  Number 
Tested 
% HBsAg 
Positivity 
%Anti-HCV 
Positivity 
χ 2 , P value 
 
History of Blood 
transfusion 
Yes 
No 
13 
87 
7.7 
5.7 
7.7 
0 
HBV 0.076, 0.783 
HCV 6.760, 0.009* 
History of 
Surgery 
Yes 
No 
31 
69 
3.2 
7.2 
3.2 
0 
HBV 0.613, 0.434 
HCV 2.248, 0.134 
Contraceptive 
use 
Yes 
No 
22 
78 
13.6 
3.8 
0 
1.3 
HBV 2.916,0.088 
HCV 0.285, 0.594 
History of 
hepatitis 
Yes 
No 
18 
82 
5.6 
6.1 
0 
1.2 
HBV 0.008, 0.930 
HCV 0.222, 0.638 
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d’Ivoire (Romero et al., 1994; Zuccotti, 2006) two countries in the same 
West African sub-region with Nigeria. This may be due to some factors such 
as educational status and lack of enlightenment/awareness of HBV and HCV 
infectivity. 
In this study, pregnancy causes no alterations in the levels of the AST 
aminotransferases. Although, the results of the liver aminotransferases 
assayed were essentially normal in all the subjects, there was a significant 
increase in ALT level when the HBsAg positive and negative pregnant 
subjects were compared. There was also a high frequency of 
HBsAgseropositivity as compared to HCV among pregnant women in this 
study and an increased serum ALT level in the positive subjects than in the 
negative subjects. This is in line with the works of Helsperet al (2012) who 
detected increase ALT in association with HCV infection in primary care 
patients. The dangers inherent in the observed cases calls for conscious 
efforts to be addressed especially as it has been reported that infection 
acquired perinatally and in early childhood is usually asymptomatic but in 
the people who experience the disease, the severity of symptoms and illness 
vary widely. 
 In conclusion, this study revealed that HBV and HCV can be present 
in pregnant women and can alter liver amino transferases. We suggest that 
free screening and immunization against HBsAg and HCV of all pregnant 
women and their infants should be incorporated into the antenatal and 
postnatal programmes in hospitals so that HBsAg and HCV positive mothers 
will receive prompt intervention. 
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